229 related articles for article (PubMed ID: 18566245)
1. Photodynamic therapy with an endocytically located photosensitizer cause a rapid activation of the mitogen-activated protein kinases extracellular signal-regulated kinase, p38, and c-Jun NH2 terminal kinase with opposing effects on cell survival.
Weyergang A; Kaalhus O; Berg K
Mol Cancer Ther; 2008 Jun; 7(6):1740-50. PubMed ID: 18566245
[TBL] [Abstract][Full Text] [Related]
2. Role of mitogen-activated protein kinase in Zn-BC-AM PDT-induced apoptosis in nasopharyngeal carcinoma cells.
Koon HK; Chan PS; Wu ZG; Wong RN; Lung ML; Chang CK; Mak NK
Cell Biochem Funct; 2010 Apr; 28(3):239-48. PubMed ID: 20373469
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy (PDT) - Initiation of apoptosis via activation of stress-activated p38 MAPK and JNK signal pathway in H460 cell lines.
Wu RW; Yow CM; Wong CK; Lam YH
Photodiagnosis Photodyn Ther; 2011 Sep; 8(3):254-63. PubMed ID: 21864799
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of MAPK signaling pathways enhances cell death induced by 5-Aminolevulinic acid-photodynamic therapy in skin squamous carcinoma cells.
Ge X; Liu J; Shi Z; Jing L; Yu N; Zhang X; Jiao Y; Wang Y; Li PA
Eur J Dermatol; 2016 Apr; 26(2):164-72. PubMed ID: 27032574
[TBL] [Abstract][Full Text] [Related]
5. Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy.
Tong Z; Singh G; Rainbow AJ
Cancer Res; 2002 Oct; 62(19):5528-35. PubMed ID: 12359764
[TBL] [Abstract][Full Text] [Related]
6. Sustained ERK [corrected] inhibition by EGFR targeting therapies is a predictive factor for synergistic cytotoxicity with PDT as neoadjuvant therapy.
Weyergang A; Selbo PK; Berg K
Biochim Biophys Acta; 2013 Mar; 1830(3):2659-70. PubMed ID: 23671927
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of stress-activated protein kinase and p38 HOG1 kinase in murine keratinocytes following photodynamic therapy with benzoporphyrin derivative.
Tao J; Sanghera JS; Pelech SL; Wong G; Levy JG
J Biol Chem; 1996 Oct; 271(43):27107-15. PubMed ID: 8900202
[TBL] [Abstract][Full Text] [Related]
8. Activation of JNK and p38 but not ERK MAP kinases in human skin cells by 5-aminolevulinate-photodynamic therapy.
Klotz LO; Fritsch C; Briviba K; Tsacmacidis N; Schliess F; Sies H
Cancer Res; 1998 Oct; 58(19):4297-300. PubMed ID: 9766656
[TBL] [Abstract][Full Text] [Related]
9. Promotion of photodynamic therapy-induced apoptosis by stress kinases.
Xue Ly; He J; Oleinick NL
Cell Death Differ; 1999 Sep; 6(9):855-64. PubMed ID: 10510467
[TBL] [Abstract][Full Text] [Related]
10. Development of resistance to photodynamic therapy (PDT) in human breast cancer cells is photosensitizer-dependent: Possible mechanisms and approaches for overcoming PDT-resistance.
Olsen CE; Weyergang A; Edwards VT; Berg K; Brech A; Weisheit S; Høgset A; Selbo PK
Biochem Pharmacol; 2017 Nov; 144():63-77. PubMed ID: 28784290
[TBL] [Abstract][Full Text] [Related]
11. The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin.
Assefa Z; Vantieghem A; Declercq W; Vandenabeele P; Vandenheede JR; Merlevede W; de Witte P; Agostinis P
J Biol Chem; 1999 Mar; 274(13):8788-96. PubMed ID: 10085120
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy with 5-aminolevulinic acid suppresses IFN-γ-induced K17 expression in HaCaT cells via MAPK pathway.
Wang XL; Sun Q
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4694-4702. PubMed ID: 29131243
[TBL] [Abstract][Full Text] [Related]
13. Activation of p38 mitogen-activated protein kinase (p38 MAPK), extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK) during hypoxia in cerebral cortical nuclei of guinea pig fetus at term: role of nitric oxide.
Maulik D; Ashraf QM; Mishra OP; Delivoria-Papadopoulos M
Neurosci Lett; 2008 Jul; 439(1):94-9. PubMed ID: 18511197
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway.
Chen L; Liu L; Yin J; Luo Y; Huang S
Int J Biochem Cell Biol; 2009 Jun; 41(6):1284-95. PubMed ID: 19038359
[TBL] [Abstract][Full Text] [Related]
15. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
16. c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases.
Sprowles A; Robinson D; Wu YM; Kung HJ; Wisdom R
Exp Cell Res; 2005 Aug; 308(2):459-68. PubMed ID: 15950217
[TBL] [Abstract][Full Text] [Related]
17. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
18. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation.
Guicheux J; Lemonnier J; Ghayor C; Suzuki A; Palmer G; Caverzasio J
J Bone Miner Res; 2003 Nov; 18(11):2060-8. PubMed ID: 14606520
[TBL] [Abstract][Full Text] [Related]
19. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.
Sopontammarak S; Aliharoob A; Ocampo C; Arcilla RA; Gupta MP; Gupta M
Cell Biochem Biophys; 2005; 43(1):61-76. PubMed ID: 16043884
[TBL] [Abstract][Full Text] [Related]
20. Mediation by arachidonic acid metabolites of the H2O2-induced stimulation of mitogen-activated protein kinases (extracellular-signal-regulated kinase and c-Jun NH2-terminal kinase).
Tournier C; Thomas G; Pierre J; Jacquemin C; Pierre M; Saunier B
Eur J Biochem; 1997 Mar; 244(2):587-95. PubMed ID: 9119028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
